Expertise in
1
conditions

Pierre Fontaine

Lille, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Lille, FR 

Overview

Pierre Fontaine practices practicing medicine in Lille, France.

Mr. Fontaine is highly rated in 1 condition, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Low Blood Sugar, and Maturity Onset Diabetes of the Young.

He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Lille, France
Other Locations
Gif-sur-yvette, 91192, France
Grenoble, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Impact of Exercise Training on Endothelial Function in Adults With Type 1 Diabetes
Impact of Exercise Training on Endothelial Function in Adults With Type 1 Diabetes
Enrollment Status: Recruiting
Publish Date: May 14, 2026
Intervention Type: Behavioral
Study Phase: Not Applicable
Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients in Terms of Mortality, Glycemic Control, and Cost Effectiveness - Prospective, Multicenter, Randomized Study
Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients in Terms of Mortality, Glycemic Control, and Cost Effectiveness - Prospective, Multicenter, Randomized Study
Enrollment Status: Completed
Publish Date: May 22, 2026
Intervention Type: Procedure, Drug
Study Phase: Phase 4
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
Enrollment Status: Completed
Publish Date: July 08, 2024
Intervention Type: Device
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Other
Study Phase: Not Applicable
In Adults With Very Unstable Type 1 Diabetes, is the DBLHU Closed-Loop Insulin Delivery System Able to Improve Blood Glycemic Control Compared to Low-Glucose-Predictive-Suspend System: Two-center, Randomized, Open-label Study
In Adults With Very Unstable Type 1 Diabetes, is the DBLHU Closed-Loop Insulin Delivery System Able to Improve Blood Glycemic Control Compared to Low-Glucose-Predictive-Suspend System: Two-center, Randomized, Open-label Study
Enrollment Status: Completed
Publish Date: May 10, 2021
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

32 Total Publications

Impact of 2-Month Exercise Training on Glycemic Metrics on Days with and without Exercise in Adults with Type 1 Diabetes.
Impact of 2-Month Exercise Training on Glycemic Metrics on Days with and without Exercise in Adults with Type 1 Diabetes.
Journal: Medicine and science in sports and exercise
Published: February 13, 2025

Frequently Asked Questions about Pierre Fontaine

Is Pierre Fontaine a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Fontaine is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Fontaine participate in research or clinical trials?

Yes. Pierre Fontaine has published 32 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Pierre Fontaine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fontaine's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile